Literature DB >> 15522738

HIFs, hypoxia, and vascular development.

Kelly L Covello1, M Celeste Simon.   

Abstract

Cellular oxygen (O2) concentrations are tightly regulated to maintain ATP levels required for metabolic reactions in the human body. Responses to changes in O2 concentrations are primarily regulated by the transcription factor hypoxia inducible factor (HIF). HIF activates transcription of genes that increase systemic O2 delivery or provide cellular metabolic adaptation under conditions of hypoxia. HIF activity is essential for embryogenesis and various processes in postnatal life, and therefore, HIF levels need to be precisely controlled. Abnormal HIF expression is related to numerous diseases of the vascular system, including heart disease, cancer, and chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522738     DOI: 10.1016/S0070-2153(04)62002-3

Source DB:  PubMed          Journal:  Curr Top Dev Biol        ISSN: 0070-2153            Impact factor:   4.897


  42 in total

1.  Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation.

Authors:  Hongxia Z Imtiyaz; Emily P Williams; Michele M Hickey; Shetal A Patel; Amy C Durham; Li-Jun Yuan; Rachel Hammond; Phyllis A Gimotty; Brian Keith; M Celeste Simon
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

2.  Essential role of B-Raf in ERK activation during extraembryonic development.

Authors:  Gergana Galabova-Kovacs; Dana Matzen; Daniela Piazzolla; Katrin Meissl; Tatiana Plyushch; Adele P Chen; Alcino Silva; Manuela Baccarini
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  NHERF1/EBP50 in Breast Cancer: Clinical Perspectives.

Authors:  Antonia Bellizzi; Andrea Malfettone; Rosa A Cardone; Anita Mangia
Journal:  Breast Care (Basel)       Date:  2010-04-09       Impact factor: 2.860

4.  Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.

Authors:  Erez Feige; Satoru Yokoyama; Carmit Levy; Mehdi Khaled; Vivien Igras; Richard J Lin; Stephen Lee; Hans R Widlund; Scott R Granter; Andrew L Kung; David E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 5.  Succinate dehydrogenase-deficient gastrointestinal stromal tumors.

Authors:  Ya-Mei Wang; Meng-Li Gu; Feng Ji
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

6.  Reversion of lethality and growth defects in Fatiga oxygen-sensor mutant flies by loss of hypoxia-inducible factor-alpha/Sima.

Authors:  Lázaro Centanin; Peter J Ratcliffe; Pablo Wappner
Journal:  EMBO Rep       Date:  2005-09-23       Impact factor: 8.807

7.  Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML.

Authors:  C E Forristal; A L Brown; F M Helwani; I G Winkler; B Nowlan; V Barbier; R J Powell; G A Engler; S M Diakiw; A C W Zannettino; S Martin; D Pattabiraman; R J D'Andrea; I D Lewis; J P Levesque
Journal:  Leukemia       Date:  2015-04-29       Impact factor: 11.528

Review 8.  Shared circuitry: developmental signaling cascades regulate both embryonic and adult coronary vasculature.

Authors:  Kory J Lavine; David M Ornitz
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

9.  O2-controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo.

Authors:  Daniel M Lewis; Michael R Blatchley; Kyung Min Park; Sharon Gerecht
Journal:  Nat Protoc       Date:  2017-07-20       Impact factor: 13.491

10.  Hemodynamic and metabolic diffuse optical monitoring in a mouse model of hindlimb ischemia.

Authors:  Rickson C Mesquita; Nicolas Skuli; Meeri N Kim; Jiaming Liang; Steve Schenkel; Amar J Majmundar; M Celeste Simon; Arjun G Yodh
Journal:  Biomed Opt Express       Date:  2010-10-15       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.